Large-scale testing (Phase 3)Not Yet RecruitingNCT00610051
What this trial is testing
ALP-1 Continuous Intravenous Infusion to Maintain Clinical Stability in Advanced Heart Failure
Who this might be right for
End Stage Cardiac FailureHFrEF - Heart Failure With Reduced Ejection FractionNYHF Class III-IV
Biopeutics Co., Ltd 600